Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

4(50.0%)

N/A

2(25.0%)

Phase 3

1(12.5%)

Phase 4

1(12.5%)

8Total

Phase 2(4)

N/A(2)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07393867Phase 2Not Yet Recruiting

Androgen-responsive POSLUMA-guided Intra-prostatic Boost

Role: collaborator

NCT07303816Phase 4Not Yet Recruiting

Statins to Prevent Cancer Associated Blood Clots

Role: collaborator

NCT06364267Phase 2Recruiting

Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.

Role: collaborator

NCT06841705Phase 2Recruiting

Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial

Role: collaborator

NCT03325985Not ApplicableCompleted

Emergency Medicine Palliative Care Access

Role: collaborator

NCT06480396Phase 3Not Yet Recruiting

High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma

Role: collaborator

NCT05284305Unknown

Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.

Role: collaborator

NCT00512850Not ApplicableCompleted

Folic Acid in Preventing Colorectal Polyps in Patients With Previous Colorectal Polyps

Role: collaborator

NCT00060099Phase 2Unknown

SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia

Role: lead

All 9 trials loaded